Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Plenary III (2803-2808)
  • Plenary
  • Bookmark Icon
  • 2804: Bimekizumab Efficacy & Safety Versus Risankizumab in Patients with Active Psoriatic Arthritis: 24-Week Results from a Head-To-Head, Multicenter, Randomized, Phase 3b Study
    • Schedule
    Notes
  • Chapin Theater
    2804
    Set Timezone

Session Type
General Topics
Format
Main Session